Add Yahoo as a preferred source to see more of our stories on Google. More than 15 million people in the U.S. are affected by COPD (chronic obstructive pulmonary disease), a condition that damages the ...

If a person has a Medicare Part D prescription drug plan, it may cover the costs of Trelegy Ellipta inhalers. Although out-of-pocket costs can vary by plan ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...

GSK plc announced that China’s National Medical Products Administration (NMPA) has approved a new indication for Trelegy Ellipta (fluticasone furoate/umeclidinium ...

More than 15 million people in the U.S. are affected by COPD (chronic obstructive pulmonary disease), a condition that damages the lungs and makes it hard to breathe. 1 But a diagnosis doesn’t have to ...